1. Home
  2. PODD
  3. PODD News

Latest Insulet Corporation (PODD) News on October 9, 2025

We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)
PODD

Simply Wall St.

4 days ago

We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)

PODD

MT Newswires

6 days ago

Rothschild & Co Redburn Adjusts Price Target on Insulet to $370 From $350, Maintains Buy Rating

Canaccord Genuity Raises Price Target on Insulet Corporation (PODD) to $399, Maintains Buy Rating
PODD

Insider Monkey

7 days ago

Canaccord Genuity Raises Price Target on Insulet Corporation (PODD) to $399, Maintains Buy Rating

Insulet Corporation (PODD) Q2 Revenue Surges 32.9% to $649M, Raises Full-Year Guidance
PODD

Insider Monkey

8 days ago

Insulet Corporation (PODD) Q2 Revenue Surges 32.9% to $649M, Raises Full-Year Guidance

PODD

MT Newswires

8 days ago

Goldman Sachs Adjusts Price Target on Insulet to $375 From $399, Maintains Buy Rating

PODD

Morningstar Research

19 days ago

Analyst Report: DexCom, Inc.

Insulet gets artistic with Omnipod Mango Pantone colour creation
PODD

Medical Device Network

21 days ago

Insulet gets artistic with Omnipod Mango Pantone colour creation

A Look At The Fair Value Of Insulet Corporation (NASDAQ:PODD)
PODD

Simply Wall St.

21 days ago

A Look At The Fair Value Of Insulet Corporation (NASDAQ:PODD)

Insulet Corporation (PODD) Benefited from Omnipod Sales
PODD

Insider Monkey

21 days ago

Insulet Corporation (PODD) Benefited from Omnipod Sales

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette
PODD

Business Wire

21 days ago

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

Why Insulet (PODD) Shares Are Falling Today
PODD

StockStory

22 days ago

Why Insulet (PODD) Shares Are Falling Today

PODD

MT Newswires

23 days ago

Piper Sandler Adjusts Insulet Price Target to $360 From $320, Maintains Overweight Rating

Insulet names new CFO; Dexcom CEO on leave
PODD

MedTech Dive

23 days ago

Insulet names new CFO; Dexcom CEO on leave

PODD

MT Newswires

23 days ago

Insulet Appoints Flavia Pease Finance Chief

Insulet Announces CFO Transition
PODD

Business Wire

23 days ago

Insulet Announces CFO Transition

Here's Why Insulet (PODD) is a Strong Momentum Stock
PODD

Zacks

24 days ago

Here's Why Insulet (PODD) is a Strong Momentum Stock

Why Insulet (PODD) is a Top Growth Stock for the Long-Term
PODD

Zacks

a month ago

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

PODD

MT Newswires

a month ago

JPMorgan Adjusts Price Target on Insulet to $415 From $340, Maintains Overweight Rating

3 Reasons Investors Love Insulet (PODD)
PODD

StockStory

a month ago

3 Reasons Investors Love Insulet (PODD)

ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know
PODD

StockStory

a month ago

ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know

PODD

MT Newswires

a month ago

Insulet Insider Sold Shares Worth $278,002, According to a Recent SEC Filing

PODD

MT Newswires

a month ago

Oppenheimer Adjusts Insulet Price Target to $365 From $324, Maintains Outperform Rating

PODD

Argus Research

a month ago

PODD: Raising target price to $362.00

Insulet (NASDAQ:PODD) shareholders have earned a 11% CAGR over the last five years
PODD

Simply Wall St.

a month ago

Insulet (NASDAQ:PODD) shareholders have earned a 11% CAGR over the last five years

Omnipod Maker Insulet Is In A Buy Zone As Its Market Expands To Millions
PODD

Investor's Business Daily

a month ago

Omnipod Maker Insulet Is In A Buy Zone As Its Market Expands To Millions

Here's Why Insulet (PODD) is a Strong Growth Stock
PODD

Zacks

a month ago

Here's Why Insulet (PODD) is a Strong Growth Stock

Insulet promotes Eric Benjamin to chief operating officer
PODD

MedTech Dive

a month ago

Insulet promotes Eric Benjamin to chief operating officer

Insulet Gains 77.2% in a Year: What's Driving the Rally?
PODD

Zacks

2 months ago

Insulet Gains 77.2% in a Year: What's Driving the Rally?

Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating
PODD

Investor's Business Daily

2 months ago

Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating

PODD

MT Newswires

2 months ago

Barclays Adjusts Price Target on Insulet to $300 From $266, Maintains Equalweight Rating

Omnipod Maker Hit A Buy Point. Here's Where To Pick Up Shares.
PODD

Investor's Business Daily

2 months ago

Omnipod Maker Hit A Buy Point. Here's Where To Pick Up Shares.

Dow Jones Futures: Palantir, Oracle, Other Growth Leaders Keep Falling; What To Do Now
PODD

Investor's Business Daily

2 months ago

Dow Jones Futures: Palantir, Oracle, Other Growth Leaders Keep Falling; What To Do Now

Insulet Stock Breaks Out — Again — As Momentum Continues
PODD

Investor's Business Daily

2 months ago

Insulet Stock Breaks Out — Again — As Momentum Continues

Insulet to Participate in Upcoming Investor Conferences
PODD

Business Wire

2 months ago

Insulet to Participate in Upcoming Investor Conferences

Diabetes stocks rally after RFK comments on HHS campaign
PODD

TipRanks

3 months ago

Diabetes stocks rally after RFK comments on HHS campaign

PODD

Argus Research

3 months ago

PODD: Raising target price to $326.00

How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?
PODD

Barchart

3 months ago

How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions
PODD

Business Wire

4 months ago

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
PODD

TipRanks

4 months ago

Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls

PODD

Investing.com

4 months ago

Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth

PODD

MT Newswires

4 months ago

Truist Initiates Insulet at Buy With $365 Price Target

1 Cash-Producing Stock with Exciting Potential and 2 to Steer Clear Of
PODD

StockStory

4 months ago

1 Cash-Producing Stock with Exciting Potential and 2 to Steer Clear Of

Insulet (NasdaqGS:PODD) Launches Omnipod 5 iPhone App With Dexcom G7 Compatibility
PODD

Simply Wall St.

4 months ago

Insulet (NasdaqGS:PODD) Launches Omnipod 5 iPhone App With Dexcom G7 Compatibility

Here's Why You Should Retain PODD Stock in Your Portfolio Now
PODD

Zacks

4 months ago

Here's Why You Should Retain PODD Stock in Your Portfolio Now

PODD

Argus Research

4 months ago

PODD: Rating decreased to a HOLD

Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users
PODD

Business Wire

4 months ago

Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption
PODD

StockStory

4 months ago

PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
PODD

Zacks

4 months ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

3 Reasons Investors Love Insulet (PODD)
PODD

StockStory

4 months ago

3 Reasons Investors Love Insulet (PODD)

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks
PODD

StockStory

4 months ago

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks

Here's Why Insulet (PODD) is a Strong Growth Stock
PODD

Zacks

4 months ago

Here's Why Insulet (PODD) is a Strong Growth Stock

PODD

MT Newswires

4 months ago

TD Cowen Adjusts Price Target on Insulet to $379 From $324

S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETF
PODD

Zacks

4 months ago

S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETF

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)
PODD

StockStory

4 months ago

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)

Solventum Stock Earns RS Rating Upgrade
PODD

Investor's Business Daily

4 months ago

Solventum Stock Earns RS Rating Upgrade

1 Surging Stock with Exciting Potential and 2 to Question
PODD

StockStory

4 months ago

1 Surging Stock with Exciting Potential and 2 to Question

PODD

Investing.com

4 months ago

Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy

PODD

MT Newswires

4 months ago

Goldman Sachs Initiates Insulet at Buy With $380 Price Target

Is Insulet Corporation (NASDAQ:PODD) A High Quality Stock To Own?
PODD

Simply Wall St.

4 months ago

Is Insulet Corporation (NASDAQ:PODD) A High Quality Stock To Own?

PODD

MT Newswires

4 months ago

Raymond James Adjusts Price Target on Insulet to $360 From $328, Maintains Outperform Rating

Insulet Gains 78.5% in a Year: What's Driving the Stock?
PODD

Zacks

4 months ago

Insulet Gains 78.5% in a Year: What's Driving the Stock?

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
PODD

Business Wire

5 months ago

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies
PODD

Zacks

5 months ago

Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies

PODD

MT Newswires

5 months ago

Citigroup Adjusts Price Target on Insulet to $380 From $320, Maintains Buy Rating

4 Medical Product Stocks to Watch From a Challenging Industry
PODD

Zacks

5 months ago

4 Medical Product Stocks to Watch From a Challenging Industry

Why Insulet (PODD) is a Top Growth Stock for the Long-Term
PODD

Zacks

5 months ago

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

PODD

MT Newswires

5 months ago

Bernstein Adjusts Insulet Price Target to $375 From $355

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest
PODD

StockStory

5 months ago

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

PODD

MT Newswires

5 months ago

Insulet Insider Sold Shares Worth $960,320, According to a Recent SEC Filing

Insulet Corporation (PODD): Among the Stocks Analysts Are Upgrading Today
PODD

Insider Monkey

5 months ago

Insulet Corporation (PODD): Among the Stocks Analysts Are Upgrading Today

Outlier Money Flows Lift Insulet
PODD

FX Empire

5 months ago

Outlier Money Flows Lift Insulet

1 Mid-Cap Stock to Target This Week and 2 to Avoid
PODD

StockStory

5 months ago

1 Mid-Cap Stock to Target This Week and 2 to Avoid

PODD

Argus Research

5 months ago

PODD: Raising target price to $346.00

PODD

MT Newswires

5 months ago

Morgan Stanley Adjusts Price Target on Insulet to $355 From $325, Maintains Overweight Rating

Insulet Announces Publication of 2024 Sustainability Report
PODD

Business Wire

5 months ago

Insulet Announces Publication of 2024 Sustainability Report

PODD

MT Newswires

5 months ago

Wolfe Research Upgrades Insulet to Outperform From Peer Perform, Price Target is $350

Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised
PODD

Zacks

5 months ago

Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised

PODD

MT Newswires

5 months ago

Redburn Atlantic Adjusts Price Target on Insulet to $350 From $315, Maintains Buy Rating

S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points
PODD

Investor's Business Daily

5 months ago

S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points

PODD

Morningstar Research

5 months ago

Analyst Report: Insulet Corporation

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks
PODD

Investopedia

5 months ago

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

Insulet Stock Soars To A High After Robust Earnings; This Customer Management Name Pops
PODD

Investor's Business Daily

5 months ago

Insulet Stock Soars To A High After Robust Earnings; This Customer Management Name Pops

Why Insulet (PODD) Stock Is Trading Up Today
PODD

StockStory

5 months ago

Why Insulet (PODD) Stock Is Trading Up Today

Insulet Stock Soars to Lead S&P 500 Gainers Friday
PODD

Investopedia

5 months ago

Insulet Stock Soars to Lead S&P 500 Gainers Friday

Insulet Q1 beat, Sweetgreen sinks on outlook, Wolfspeed drops
PODD

Yahoo Finance Video

5 months ago

Insulet Q1 beat, Sweetgreen sinks on outlook, Wolfspeed drops

Insulet (NasdaqGS:PODD) Announces $125M Buyback, Raises Revenue Guidance For 2025
PODD

Simply Wall St.

5 months ago

Insulet (NasdaqGS:PODD) Announces $125M Buyback, Raises Revenue Guidance For 2025

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More
PODD

Investopedia

5 months ago

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

PODD

MT Newswires

5 months ago

RBC Raises Price Target on Insulet to $330 From $325, Keeps Outperform Rating

PODD

Thomson Reuters StreetEvents

5 months ago

Q1 2025 Insulet Corp Earnings Call

Dow Jones Futures Rise As Trump Says 80% China Tariff 'Seems Right'; Robinhood Leads 6 New Buys
PODD

Investor's Business Daily

5 months ago

Dow Jones Futures Rise As Trump Says 80% China Tariff 'Seems Right'; Robinhood Leads 6 New Buys

PODD

MT Newswires

5 months ago

Canaccord Genuity Lifts Price Target on Insulet to $331 From $324, Maintains Buy Rating

PODD

MT Newswires

5 months ago

Oppenheimer Adjusts Price Target on Insulet to $324 From $312, Maintains Outperform Rating

PODD

MT Newswires

5 months ago

Baird Adjusts Price Target on Insulet to $350 From $325, Maintains Outperform Rating

PODD

MT Newswires

5 months ago

Wells Fargo Adjusts Price Target on Insulet to $330 From $322, Maintains Overweight Rating

PODD

MT Newswires

5 months ago

Bernstein Adjusts Price Target on Insulet to $355 From $335, Maintains Outperform Rating

What To Expect From Insulet’s (PODD) Q1 Earnings
PODD

StockStory

5 months ago

What To Expect From Insulet’s (PODD) Q1 Earnings

PODD

Argus Research

5 months ago

PODD: Raising target price to $285.00

Curious about Insulet (PODD) Q1 Performance? Explore Wall Street Estimates for Key Metrics
PODD

Zacks

5 months ago

Curious about Insulet (PODD) Q1 Performance? Explore Wall Street Estimates for Key Metrics

1 Growth Stock with Impressive Fundamentals and 2 to Think Twice About
PODD

StockStory

5 months ago

1 Growth Stock with Impressive Fundamentals and 2 to Think Twice About

PODD

MT Newswires

5 months ago

Insulet Shares Fall After Wolfe Research Downgrade

Share on Social Networks: